TRBC1

TRBC1 Molekülinformation

Englischer Name	TRBC1	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	4	Target-Alias	T cell receptor beta constant 1，TRBC1，V_segment Translation Product，BV05S1J2.2，TCRBC1，TCRB
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	TRBC1
Target-Alias	T cell receptor beta constant 1，TRBC1，V_segment Translation Product，BV05S1J2.2，TCRBC1，TCRB
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	4
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

TRBC1 Produktliste

Attribut
Protein (2)
Produktbibliothek
Online (2)
Spezies
Human (2)
Etikett
His Tag (1)His Tag & Avi Tag (1)
Marker
Unconjugated (1)Biotin-labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
TR1-H52H4	Human	HEK293	Human TRBC1 Protein, His Tag (HPLC verified)				In den Warenkorb legen
TR1-H82E6	Human	HEK293	Biotinylated Human TRBC1 Protein, His,Avitag™				In den Warenkorb legen

Gesamtmenge2

TRBC1 Molekülhintergrund

The transmembrane protein, TCR, comprise of two disulphide-linked polypeptide chains: a α and β chain, a γ and δ chain. Each polypeptide chain consists of a variable and a constant region. TRBC1 is the constant region of T-cell receptor (TCR) beta chain. TRBC1 is presented on the surface of T cell and recognized peptide-major histocompatibility (MH) (pMH) that are displayed by antigen presenting cells (APC). TRBC1 is participate in an adaptive immune response and has been well-studied in T cell therapy.

TRBC1 Molekülalias

T cell receptor beta constant 1,TRBC1

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Invikafusp Alfa	STAR0602; STAR-0602	Phase 2 Clinical	Marengo Therapeutics Inc	Abdominal Neoplasms; Breast Neoplasms; Carcinoma; Epstein-Barr Virus Infections; Lung Neoplasms; Neoplasms; Papillomavirus Infections; Solid tumours; Triple Negative Breast Neoplasms; Urogenital Neoplasms; Vulvar Diseases; Vulvar Neoplasms	Details
TRBC1/2-Targeted CAR-T Cell Therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)		Phase 1 Clinical	Second Affiliated Hospital School Of Zhejiang University School Of Medicine	Lymphoma, T-Cell, Peripheral	Details
Anti-TRBC1 CAR-T cell therapy (Shanghai General Hospital)		Phase 1 Clinical	Shanghai General Hospital	Hematologic Neoplasms	Details
FT-819	FT-8198; FT-819; FT 8198	Phase 1 Clinical	Memorial Sloan Kettering Cancer Center	Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Myositis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Scleroderma, Systemic	Details

Produktrezensionen

1***82022-08-03
0Menschen mögen
Human TRBC1 Protein, His Tag (HPLC verified)
The TRBC1 protein is really helpful! Recently, our experiment has not been smooth UNTIL we used the TRBC1 protein and then things finally started to come together! It turns out we were not using the right protein which stopped us from continuing our project. Thank you so much!